vs
Side-by-side financial comparison of Gloo Holdings, Inc. (GLOO) and Entrada Therapeutics, Inc. (TRDA). Click either name above to swap in a different company.
Gloo Holdings, Inc. is the larger business by last-quarter revenue ($32.6M vs $20.6M, roughly 1.6× Entrada Therapeutics, Inc.). Entrada Therapeutics, Inc. runs the higher net margin — -84.4% vs -116.9%, a 32.5% gap on every dollar of revenue. Entrada Therapeutics, Inc. produced more free cash flow last quarter ($-39.7M vs $-63.4M).
Entrada Therapeutics is a clinical-stage biotechnology firm developing transformative intracellular therapies for serious rare diseases and high-unmet-need disorders. Its pipeline covers neuromuscular, metabolic, and central nervous system segments, serving global patients via healthcare partnerships.
GLOO vs TRDA — Head-to-Head
Income Statement — Q3 FY2026 vs Q1 FY2025
| Metric | | |
|---|---|---|
| Revenue | $32.6M | $20.6M |
| Net Profit | $-38.0M | $-17.3M |
| Gross Margin | — | — |
| Operating Margin | -82.0% | -106.0% |
| Net Margin | -116.9% | -84.4% |
| Revenue YoY | — | -65.2% |
| Net Profit YoY | 12.2% | -173.8% |
| EPS (diluted) | $-6.08 | $-0.42 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $32.6M | — | ||
| Q1 25 | — | $20.6M | ||
| Q4 24 | — | $37.4M | ||
| Q3 24 | — | $19.6M | ||
| Q2 24 | — | $94.7M | ||
| Q1 24 | — | $59.1M | ||
| Q4 23 | — | $41.8M | ||
| Q3 23 | — | $43.7M |
| Q4 25 | $-38.0M | — | ||
| Q1 25 | — | $-17.3M | ||
| Q4 24 | — | $1.1M | ||
| Q3 24 | — | $-14.0M | ||
| Q2 24 | — | $55.0M | ||
| Q1 24 | — | $23.5M | ||
| Q4 23 | — | $-9.5M | ||
| Q3 23 | — | $35.5M |
| Q4 25 | -82.0% | — | ||
| Q1 25 | — | -106.0% | ||
| Q4 24 | — | -15.7% | ||
| Q3 24 | — | -110.7% | ||
| Q2 24 | — | 56.4% | ||
| Q1 24 | — | 35.7% | ||
| Q4 23 | — | 11.7% | ||
| Q3 23 | — | 32.0% |
| Q4 25 | -116.9% | — | ||
| Q1 25 | — | -84.4% | ||
| Q4 24 | — | 3.0% | ||
| Q3 24 | — | -71.7% | ||
| Q2 24 | — | 58.1% | ||
| Q1 24 | — | 39.7% | ||
| Q4 23 | — | -22.8% | ||
| Q3 23 | — | 81.1% |
| Q4 25 | $-6.08 | — | ||
| Q1 25 | — | $-0.42 | ||
| Q4 24 | — | $-0.20 | ||
| Q3 24 | — | $-0.35 | ||
| Q2 24 | — | $1.55 | ||
| Q1 24 | — | $0.68 | ||
| Q4 23 | — | $-0.23 | ||
| Q3 23 | — | $1.02 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $15.1M | $67.8M |
| Total DebtLower is stronger | $176.5M | — |
| Stockholders' EquityBook value | $-444.4M | $417.3M |
| Total Assets | $206.7M | $486.5M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $15.1M | — | ||
| Q1 25 | — | $67.8M | ||
| Q4 24 | — | $101.2M | ||
| Q3 24 | — | $78.0M | ||
| Q2 24 | — | $185.3M | ||
| Q1 24 | — | $68.4M | ||
| Q4 23 | — | $67.6M | ||
| Q3 23 | — | $51.9M |
| Q4 25 | $176.5M | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | — | ||
| Q3 23 | — | — |
| Q4 25 | $-444.4M | — | ||
| Q1 25 | — | $417.3M | ||
| Q4 24 | — | $428.7M | ||
| Q3 24 | — | $422.4M | ||
| Q2 24 | — | $429.9M | ||
| Q1 24 | — | $269.4M | ||
| Q4 23 | — | $242.4M | ||
| Q3 23 | — | $246.7M |
| Q4 25 | $206.7M | — | ||
| Q1 25 | — | $486.5M | ||
| Q4 24 | — | $526.3M | ||
| Q3 24 | — | $554.6M | ||
| Q2 24 | — | $582.0M | ||
| Q1 24 | — | $510.8M | ||
| Q4 23 | — | $469.2M | ||
| Q3 23 | — | $485.0M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-63.0M | $-38.5M |
| Free Cash FlowOCF − Capex | $-63.4M | $-39.7M |
| FCF MarginFCF / Revenue | -194.8% | -192.9% |
| Capex IntensityCapex / Revenue | 1.4% | 5.6% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-58.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-63.0M | — | ||
| Q1 25 | — | $-38.5M | ||
| Q4 24 | — | $-31.6M | ||
| Q3 24 | — | $-24.3M | ||
| Q2 24 | — | $39.8M | ||
| Q1 24 | — | $-25.5M | ||
| Q4 23 | — | $-4.0M | ||
| Q3 23 | — | $-24.5M |
| Q4 25 | $-63.4M | — | ||
| Q1 25 | — | $-39.7M | ||
| Q4 24 | — | $-32.2M | ||
| Q3 24 | — | $-24.9M | ||
| Q2 24 | — | $38.8M | ||
| Q1 24 | — | $-26.4M | ||
| Q4 23 | — | $-5.0M | ||
| Q3 23 | — | $-25.9M |
| Q4 25 | -194.8% | — | ||
| Q1 25 | — | -192.9% | ||
| Q4 24 | — | -86.2% | ||
| Q3 24 | — | -127.3% | ||
| Q2 24 | — | 41.0% | ||
| Q1 24 | — | -44.6% | ||
| Q4 23 | — | -11.9% | ||
| Q3 23 | — | -59.3% |
| Q4 25 | 1.4% | — | ||
| Q1 25 | — | 5.6% | ||
| Q4 24 | — | 1.7% | ||
| Q3 24 | — | 3.3% | ||
| Q2 24 | — | 1.1% | ||
| Q1 24 | — | 1.4% | ||
| Q4 23 | — | 2.3% | ||
| Q3 23 | — | 3.3% |
| Q4 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | -27.94× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 0.72× | ||
| Q1 24 | — | -1.09× | ||
| Q4 23 | — | — | ||
| Q3 23 | — | -0.69× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
GLOO
| Platform Solutions | $12.7M | 39% |
| Advertising | $11.1M | 34% |
| Marketplace | $3.9M | 12% |
| Midwestern Acquisition | $2.7M | 8% |
| Servant Acquisition | $1.8M | 6% |
TRDA
Segment breakdown not available.
